Istituto di Chimica Biomolecolare, Consiglio Nazionale delle Ricerche, Rome, Italy.
PLoS One. 2010 Jan 28;5(1):e8927. doi: 10.1371/journal.pone.0008927.
The taurine amino-acid derivative, taurolidine, bis-(1,1-dioxoperhydro-1,2,4-thiabiazinyl-4)methane, shows broad antibacterial action against gram-positive and gram-negative bacteria, mycobacteria and some clinically relevant fungi. It inhibits, in vitro, the adherence of Escherichia coli and Staphylococcus aureus to human epithelial and fibroblast cells. Taurolidine is unstable in aqueous solution and breaks down into derivatives which are thought to be responsible for the biological activity. To understand the taurolidine antibacterial mechanism of action, we provide the experimental single crystal X-ray diffraction results together with theoretical methods to characterize the hydrolysis/decomposition reactions of taurolidine. The crystal structure features two independent molecules linked through intermolecular H-bonds with one of them somewhat positively charged. Taurolidine in a biological environment exists in equilibrium with taurultam derivatives and this is described theoretically as a 2-step process without an energy barrier: formation of cationic taurolidine followed by a nucleophilic attack of O(hydroxyl) on the exocyclic C(methylene). A concerted mechanism describes the further hydrolysis of the taurolidine derivative methylol-taurultam. The interaction of methylol-taurultam with the diaminopimelic NH(2) group in the E. coli bacteria cell wall (peptidoglycan) has a negative DeltaG value (-38.2 kcal/mol) but a high energy barrier (45.8 kcal/mol) suggesting no reactivity. On the contrary, taurolidine docking into E. coli fimbriae protein, responsible for bacteria adhesion to the bladder epithelium, shows it has higher affinity than mannose (the natural substrate), whereas methylol-taurultam and taurultam are less tightly bound. Since taurolidine is readily available because it is administered in high doses after peritonitis surgery, it may successfully compete with mannose explaining its effectiveness against bacterial infections at laparoscopic lesions.
牛磺酸氨基酸衍生物牛磺脒,双-(1,1-二氧代-1,2,4-噻嗪-4-基)甲烷,对革兰氏阳性和革兰氏阴性细菌、分枝杆菌和一些临床相关真菌具有广泛的抗菌作用。它在体外抑制大肠杆菌和金黄色葡萄球菌与人上皮细胞和成纤维细胞的黏附。牛磺脒在水溶液中不稳定,会分解成被认为具有生物活性的衍生物。为了了解牛磺脒的抗菌作用机制,我们提供了实验单晶 X 射线衍射结果以及理论方法来表征牛磺脒的水解/分解反应。晶体结构特征是两个通过分子间氢键连接的独立分子,其中一个分子略带正电荷。在生物环境中,牛磺脒与牛磺脒衍生物处于平衡状态,这在理论上被描述为一个没有能量障碍的 2 步过程:形成正电荷的牛磺脒,然后亲核攻击环外 C(亚甲基)上的 O(羟基)。协同机制描述了牛磺脒衍生物羟甲基牛磺脒的进一步水解。羟甲基牛磺脒与大肠杆菌细胞壁(肽聚糖)中二氨基庚二酸 NH(2)基团的相互作用具有负的 DeltaG 值(-38.2 kcal/mol),但能量障碍较高(45.8 kcal/mol),表明没有反应性。相反,牛磺脒与负责细菌黏附到膀胱上皮的大肠杆菌菌毛蛋白的对接表明,它与甘露糖(天然底物)相比具有更高的亲和力,而羟甲基牛磺脒和牛磺脒的结合力较弱。由于牛磺脒在腹膜炎手术后以高剂量给药,因此很容易获得,它可能会成功地与甘露糖竞争,解释其在腹腔镜损伤时对抗细菌感染的有效性。